Table 4.
Best overall responses in patients with assessments using with mRECIST criteria
| Assessment using mRECIST | ||
|---|---|---|
| (n = 494) | ||
| Best overall response, n (%) | ||
| Complete response | 36 | (7.3) |
| Partial response | 159 | (32.2) |
| Stable disease | 195 | (39.5) |
| Progressive disease | 104 | (21.1) |
| Not evaluable | 0 | (0.0) |
| ORRa, % (95 % CI) | 39.5 | (35.1–43.9) |
| DCRb, % (95 % CI) | 78.9 | (75.1–82.5) |
CI confidence interval, DCR disease control rate, mRECIST modified Response Evaluation Criteria in Solid Tumors, ORR objective response rate
aORR = proportion of patients with complete response and partial response
bDCR = proportion of patients with complete response, partial response, and stable disease